In the ever-evolving battle against infectious diseases, the rise of drug-resistant infections poses a significant challenge to global health. These resilient bugs have developed mechanisms to withstand conventional treatments, leaving scientists and healthcare professionals searching for innovative solutions.

Henrietta Lacks, an African-American woman, unknowingly contributed to one of the most significant advancements in medical science when cells taken from her cervical cancer biopsy in 1951 were used to create the first immortal human cell line, known as HeLa cells.

In the ever-evolving landscape of medical research, drug repurposing has emerged as a groundbreaking approach, proving that sometimes old dogs can indeed learn new tricks.  Drug repurposing, also known as drug repositioning or drug reprofiling, refers to the process of identifying new uses for existing drugs that are already approved for other indications.

COVID-19 began as an unexplained respiratory illness in Wuhan, China and quickly spread throughout the world, killing millions of people.

Artificial Intelligence (AI) is revolutionizing the field of cancer immunotherapy by accelerating the discovery, development, and delivery of innovative treatments. Here is a breakdown of its potential role: Drug Discovery: AI algorithms can analyze vast amounts of genomic, proteomic, and clinical data to identify potential drug targets and predict the efficacy of immunotherapies.

In today’s fast-evolving digital landscape, digital employee experience (DEx) is more than just a buzzword—it’s an essential aspect of organizational success, particularly for professionals like medical writers.